C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 5/18 (2006.01) A61K 39/395 (2006.01) C07K 16/28 (2006.01) G01N 33/566 (2006.01) G01N 33/577 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2170606
The present invention relates to a novel hybridoma cell line which secretes monoclonal antibodies capable of binding to the AT1 subtype of the Angiotensin II receptor. It also relates to monoclonal antibodies secreted by the hybridoma, which antibodies may be used in diagnostic test kits as well as having therapeutic applications.
L'invention se rapporte à une nouvelle lignée cellulaire d'hybridome qui secrète des anticorps monoclonaux capables de se fixer au récepteur du sous-type AT¿1? de l'angiotensine II. L'invention se rapporte également aux anticorps monoclonaux sécrétés par l'hybridome que l'on peut utiliser dans des nécessaires pour tests diagnostiques, ces anticorps ayant également des applications thérapeutiques.
Barker Stewart
Vinson Gavin Paul
Gowling Lafleur Henderson Llp
Queen Mary And Westfield College
LandOfFree
Type i angiotensin ii receptor specific monoclonal... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Type i angiotensin ii receptor specific monoclonal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Type i angiotensin ii receptor specific monoclonal... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1927868